TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 7 Feb 2024, 12:06 GMT

Official UK procurement notice

Generic, Branded Generic & Proprietary Medicinal Products - Group 18

Official notice

Authority: Regional Business Services Organisation Procurement and Logistics Service·Consortium: 4 public authorities

Dynamic marketGoodsRestricted procedure
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)
Dynamic market estimate£1,800,000,000market-wide estimate, not attributable revenue
Submission deadline 23 Feb 2029853d 15h left

What is being bought

Published requirement description

Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)

CPV: Pharmaceutical products

How this dynamic market works

From the published notice
Type
Dynamic market
Bids received
60 bids received · 85 suppliers appointed

The lotProcurement structure

single lot · value published
Lot #1Eighteenth group tender for Generic, Branded Generic & Proprietary Medicinal ProductsAwardedRenewalPublished value£1,800,000,000

Eighteenth group tender for Generic, Branded Generic & Proprietary Medicinal Products. Additional information: The estimated total value of contract (excluding VAT) is GBP 11,409,969.64 to GBP 64,181,079.24. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial

Conditions of Contract for Supplies Contracts documents and provides for potential growth of up to 50% over the course of the contract.

Delivery: Northern Ireland · Various locations throughout Northern Ireland
Extensions: It is likely that most contracts awarded using the DPS will be renewed for purposes of continued supply. The product range of each contract may, however, change on each renewal. Some contracts may be restructured, merged, divided or no longer required.Variant bids: not allowed
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
Quality: 58%Price: 42%
Published sub-criteria (5)
  • Award Criteria (Technical Envelope): Supply and Delivery of Product (Same Working Day Delivery): 5%
  • Award Criteria (Technical Envelope): Supply and Delivery of Product (Wholesale Distribution): 5%
  • Award Criteria (Technical Envelope): Continuity of Supply (Minimum Committed Stockholding): 8%
  • Award Criteria (Technical Envelope): Governance, Quality Control and Risk (Pharmaceutical Quality Assessment (PQA) Section 2 - Section 6): 40%
  • price: 42%
Published award criteria (10)
  • Award Criteria (Eligibility Envelope): Compliance with Contract Scope and Specification: Pass/Fail
  • Award Criteria (Eligibility Envelope): Supply and Delivery of Product (i) (Evidence of Compliance with Good Distribution Practice (GDP) Requirements, as outlined in the Contract Scope and Specification): Pass/Fail
  • Award Criteria (Eligibility Envelope): Supply and Delivery of Product (ii) (Evidence of compliance with the Medical Device supply / EU Authorised Representative requirements as outlined in the Contract Scope and Specification): Pass/Fail
  • Award Criteria (Eligibility Envelope): Registration on the NHS Evergreen Sustainable Supplier Assessment platform, as outlined in the Contract Scope and Specification): Pass/Fail
  • Award Criteria (Technical Envelope): Supply and Delivery of Product (Same Working Day Delivery): 5%
  • Award Criteria (Technical Envelope): Supply and Delivery of Product (Wholesale Distribution): 5%
  • Award Criteria (Technical Envelope): Continuity of Supply (Minimum Committed Stockholding): 8%
  • Award Criteria (Eligibility Envelope): Governance, Quality Control and Risk (Pharmaceutical Quality Assessment (PQA) Section 1): Pass/Fail
  • Award Criteria (Technical Envelope): Governance, Quality Control and Risk (Pharmaceutical Quality Assessment (PQA) Section 2 - Section 6): 40%
  • Price: 42%
Conditions of participation2
  • Suitability

    Selection criteria for appointment to the DPS are detail in the documentation. There is no anticipated limited on

    the number of candidates who may qualify for appointment to the DPS.

  • Economic & financial standing

    Selection criteria for appointment to the DPS are detail in the documentation. There is no anticipated limited on

    the number of candidates who may qualify for appointment to the DPS.

    Minimum: Selection criteria for appointment to the DPS are detail in the documentation. There is no anticipated limited on the number of candidates who may qualify for appointment to the DPS.
What this means for your bid
  • Price carries 42 of 100 points: a 10% discount moves about 4.2 points. Quality carries 58 of 100: the paper moves it further than the discount.
  • “Generic, Branded Generic & Proprietary Medicinal Products - Group 18” is a dynamic market: the contest is a place on its panel, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Restricted procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Dynamic market
Who may use this agreement
Any qualifying supplier may apply while the market is open
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Yes
First published
7 Feb 2024, 12:06 GMT
Last source update
3 Jul 2026, 13:48 BST
Authority reference
6345404
FTS notice number
2026/S 000-062803
Classification (CPV)
Pharmaceutical products
Delivery area
Northern Ireland (UKN)
Official registry OCID
ocds-h6vhtk-0437e0 Find a Tender

Publisher note: The total value of contract (detailed in section V.2.4)) awarded to each of the contractors indicated in this notice is based on an initial contract period of 24 months. It is important to note that there is available provision to extend this initial contract period in accordance with Section 2 of the SS17bc Commercial Conditions of Contract for Supplies Contracts document

How it was run

Official notice
Run through: eTendersNI · Who buys & how to bid on eTendersNI
Supplier login requiredLanguage: EN
Access & registration note: Free Northern Ireland registration
Admission period ends
23 Feb 2029
Submission channel
{"electronicSubmission"}
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

etendersni.gov.uk/epps/home.do ↗

Timeline

3 Jul 2026 → 23 Feb 2029 · 2 dates
  1. Notice published112 days ago
    3 Jul 2026, 13:48 BST
  2. Today
    23 Oct 2026
  3. Admission / appointment period endsperiod end, not a bid countdown
    23 Feb 2029

Notice history

8 events · 10 releases on Find a Tender · since 14 Feb 2024
  1. Status changed to complete
    14 Feb 2024, 08:43 GMT
  2. Buyer details updated
    14 Feb 2024, 08:43 GMT
  3. Buyer details updated
    15 Aug 2024, 09:43 BST
  4. Buyer details updated
    16 Aug 2024, 10:50 BST
  5. Buyer details updated
    16 Aug 2024, 10:56 BST
  6. Deadline moved to 23 Feb 2029
    1 Jul 2025, 14:53 BST
    +1167 days · was 14 Dec 2025
  7. Buyer details updated
    1 Jul 2025, 14:53 BST
  8. Buyer details updated
    21 Aug 2025, 11:45 BST
Published amendments (3 · 1 deadline change)
WhenWhatBeforeAfterShift
—DeadlineIV.2.214 Dec 202523 Feb 2029+1167 d

Section II: Object 1.7 Total Value of Procurement (excluding VAT) Additional information The estimated total value of contract (excluding VAT) is GBP 13,873,205 to GBP 78,036,778. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts documents and provides for p…

Section II: Object 1.7 Total Value of Procurement (excluding VAT) Additional information The estimated total value of contract (excluding VAT) is GBP 10,726,540 to GBP 60,336,782. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts documents and provides for p…

This DPS has been extended to 23 February 2029 in line with the updated regulations under Procurement Act 2023.

Routine re-releases (10)
  • 2025-07: 1 release · 1 Jul 2025
  • 2025-01: 1 release · 24 Jan 2025
  • 2024-08: 3 releases · 15 Aug 2024, 16 Aug 2024
  • 2024-02: 2 releases · 7 Feb 2024, 14 Feb 2024

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 85admitted to the panel · see the list ↓
Bids received 60
Contracts signed 20latest 23 Jun 2026

214 suppliers are admitted to this dynamic market without individual award values or dates, see the supplier list below.

Contracts

  • Contract 062803-2026-6345404-1

    Signed
    23 Jun 2026
    Value
    £7,936
    Status
    active

  • Contract 062803-2026-6345404-10

    Signed
    23 Jun 2026
    Value
    £560,152
    Status
    active

  • Contract 062803-2026-6345404-11

    Signed
    23 Jun 2026
    Value
    £206,514
    Status
    active

  • Contract 062803-2026-6345404-13

    Signed
    23 Jun 2026
    Value
    £380,084
    Status
    active

  • Contract 062803-2026-6345404-14

    Signed
    23 Jun 2026
    Value
    £42,646
    Status
    active

  • Contract 062803-2026-6345404-15

    Signed
    23 Jun 2026
    Value
    £9,333
    Status
    active

  • Contract 062803-2026-6345404-16

    Signed
    23 Jun 2026
    Value
    £26,228
    Status
    active

  • Contract 062803-2026-6345404-17

    Signed
    23 Jun 2026
    Value
    £2,003,241
    Status
    active

  • Contract 062803-2026-6345404-18

    Signed
    23 Jun 2026
    Value
    £76,180
    Status
    active

  • Contract 062803-2026-6345404-19

    Signed
    23 Jun 2026
    Value
    £148,004
    Status
    active

  • Contract 062803-2026-6345404-2

    Signed
    23 Jun 2026
    Value
    £5,205
    Status
    active

  • Contract 062803-2026-6345404-20

    Signed
    23 Jun 2026
    Value
    £228,284
    Status
    active

  • Contract 062803-2026-6345404-21

    Signed
    23 Jun 2026
    Value
    £66,755
    Status
    active

  • Contract 062803-2026-6345404-22

    Signed
    23 Jun 2026
    Value
    £12,960
    Status
    active

  • Contract 062803-2026-6345404-23

    Signed
    23 Jun 2026
    Value
    £139,224
    Status
    active

  • Contract 062803-2026-6345404-24

    Signed
    23 Jun 2026
    Value
    £31,331
    Status
    active

  • Contract 062803-2026-6345404-25

    Signed
    23 Jun 2026
    Value
    £13,793
    Status
    active

  • Contract 062803-2026-6345404-26

    Signed
    23 Jun 2026
    Value
    £977,459
    Status
    active

  • Contract 062803-2026-6345404-27

    Signed
    23 Jun 2026
    Value
    £8,680
    Status
    active

  • Contract 062803-2026-6345404-28

    Signed
    23 Jun 2026
    Value
    £615,625
    Status
    active

Bid statistics published by the authority

BidsSMEVCSEValid bid range
60bids———

Contracting authority & participating public bodies

3 public bodies on the notice

Regional Business Services Organisation, Procurement and Logistics Service

Contracting authorityBody governed by public lawHealth 77 Boucher Crescent, Belfast, Northern Ireland, BT126HUContact name, email, phone

Consortium members and other public bodies

  • Procurement & Logistics ServiceContracting authorityCentral purchasing bodyBody governed by public lawHealth BELFAST, Northern IrelandContact name, email, phone
  • Procurement and Logistics ServiceContracting authorityBody governed by public lawHealth BELFAST, Northern IrelandContact name, email, phone

Dispute resolution & review bodies

Suppliers admitted to the dynamic market

89 commercial parties on the notice · 50 awarded

The first 50 of 89 commercial parties (by name); the JSON mirror lists them all.

  • AGB PharmaAdmitted to the marketGB-COH: 11316999 Lund, SE
  • AOP Orphan LtdAdmitted to the marketGB-COH: 08082765 Weybridge, UK, KT13
  • Abbvie LtdAdmitted to the marketGB-COH: 08004972 ABBVIE HOUSE, MAIDENHEAD, UK, SL6 4UBContact email, phone
  • Accord UK LtdAdmitted to the marketGB-COH: 00079585 WHIDDON VALLEY, BARNSTAPLE, UK, EX32 8NSContact email, phone
  • Aguettant LtdAdmitted to the marketGB-COH: 04966231 Bristol, UK, BS48 1UR
  • AllianceAdmitted to the marketGB-COH: 03446039 Chesington, UK
  • Amarox LtdAdmitted to the marketGB-COH: 10997632 Congress House 14 Lyon Road, Harrow, UK, HA1 2ENContact email, phone
  • Aspire Pharma LtdAdmitted to the marketGB-COH: 06828501 Bellamy House, Petersfield, UK, GU31 4AD
  • AstrazenecaAdmitted to the marketGB-COH: 02723534 Luton, UK
  • Aventis Pharma LtdAdmitted to the marketGB-COH: 01535640 410 Thames Valley Park Drive, Reading, UK, RG6 1PT
Show 40 more suppliers

Official documents & specifications (1)

Official links; attachments are not copied

Tender pack and attachments

  • Technical selection criteriatenderTechnical selection criteria